Cite

HARVARD Citation

    Overgaard, R. et al. (2019). Impact on HbA1c and body weight of switching from other GLP‐1 receptor agonists to semaglutide: A model‐based approach. Diabetes, obesity & metabolism. 21 (1), pp. 43-51. [Online]. 
  
Back to record